| GENFIT S.A. EO -,25 |
| Frankreich |
| Gesundheit |
| FR0004163111 / A0LGJ2 |
| XUP (Frankfurt) |
| FRA:XUP, ETR:XUP, XUP:GR |
| - |
| https://www.genfit.com/ |
|
Genfit S.A. is a BCorp™ certified biopharmaceutical company specializing in the discovery and development of therapeutic solutions for rare and life-threatening liver diseases with high unmet medical needs. As a pioneer in liver disease research wi..
>Volltext.. |
| 456.71 Mio. EUR |
| 506.5 Mio. EUR |
| 65.47 Mio. EUR |
| -8.04 Mio. EUR |
| -86.02 Mio. EUR |
| -1.73 EUR |
| 150.77 Mio. EUR |
| 101.15 Mio. EUR |
| -25.34 Mio. EUR |
| 1.4 |
| -2.34% |
| -5804.58% |
| - |
| - |
| - |
| - |
| GENFIT |
| 22.04.26 |
|